CD158b (KIR2DL2/DL3) antibodies, human

CD158b (KIR2DL2/DL3) antibodies, human

Clone: REA1006 | Dilution: 1:50
Clone REA1006 recognizes the human CD158b1 (KIR2DL2), CD158b2 (KIR2DL3), and CD158j (KIR2DS2) antigens, members of the killer immunoglobulin-like receptor (KIR) family expressed on natural killer (NK) cells and subsets of T cells.
KIRs contribute to the regulation of NK cell–mediated cytotoxicity and possess high allelic polymorphism with either 2 or 3 Ig-like extracellular domains. According to the length of their cytoplasmic tail, KIRs can be further subdivided in inhibitory KIRs (KIR2DL or KIR3DL) and activating KIRs (KIR2DS or KIR3DS). CD158b provides an inhibitory signal on NK cell lytic activity upon interaction with HLA C (e.g. alleles HLA-Cw1, HLA-Cw3, HLA-Cw7) in an antigen-independent manner.
Additional information: Clone REA1006 displays negligible binding to Fc receptors.

Alternative Names

KIR2DL2, KIR2DL3, KIR2DS2

Technical specifications

  • Antigen: CD158b (KIR2DL2/DL3)
  • Clone: REA1006
  • Isotype: recombinant human IgG1
  • Isotype control: REA Control (S) antibodies
  • Alternative names of antigen: KIR2DL2, KIR2DL3, KIR2DS2
  • Entrez Gene ID: 3803, 3804
  • Molecular mass of antigen [kDa]: 36
  • Distribution of antigen: NK cells, T cells
  • Product format: Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.
  • Fixation: Cells should be stained prior to fixation, if formaldehyde is used as a fixative.
  • Storage: Store protected from light at 2–8 °C. Do not freeze.
  • Available conjugates: FITC, PE, PE-Vio615, PE-Vio770, APC-Vio770, VioBright 515
  • Selected References

    1. Selvakumar, A. et al. (1997) Polymorphism and domain variability of human killer cell inhibitory receptors. Immunol. Rev. 155: 183-196
    2. Djeu, J. et al. (2002) A view to a kill: signals triggering cytotoxicity. Clin. Cancer Res. 8: 636-640
    3. Farag, S. S. et al. (2002) Natural killer cell receptors: new biology and insights into the graft-versus-leukaemia effect. Blood 100(6): 1935-1947
    4. Hsu, K. et al. (2002) The killer cell immunoglobin-like (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol. Rev. 190: 40-52

Related products

3 products available
Product options: 9

Product information

Size
Order no.
Price

CD158b (KIR2DL2/DL3)-PE, human

  • REA1006
  • 1:50
  • For research use only
for 30
tests
(1)
130-116-952
EUR 110,00 

CD158b (KIR2DL2/DL3)-PE, human

  • REA1006
  • 1:50
  • For research use only
for 100
tests
(1)
130-116-832
EUR 265,00 

CD158b (KIR2DL2/DL3)-PE-Vio615, human

  • REA1006
  • 1:50
  • For research use only
for 30
tests
(1)
130-116-954
EUR 120,00 

CD158b (KIR2DL2/DL3)-PE-Vio615, human

  • REA1006
  • 1:50
  • For research use only
for 100
tests
(1)
130-116-834
EUR 290,00 

CD158b (KIR2DL2/DL3)-PE-Vio770, human

  • REA1006
  • 1:50
  • For research use only
for 100
tests
(1)
130-116-835
EUR 290,00 

CD158b (KIR2DL2/DL3)-APC-Vio770, human

  • REA1006
  • 1:50
  • For research use only
for 30
tests
(1)
130-116-956
EUR 120,00 

CD158b (KIR2DL2/DL3)-APC-Vio770, human

  • REA1006
  • 1:50
  • For research use only
for 100
tests
(1)
130-116-836
EUR 290,00 

CD158b (KIR2DL2/DL3)-VioBright 515, human

  • REA1006
  • 1:50
  • For research use only
for 30
tests
(1)
130-116-957
EUR 150,00 

CD158b (KIR2DL2/DL3)-VioBright 515, human

  • REA1006
  • 1:50
  • For research use only
for 100
tests
(1)
130-116-837
EUR 360,00